| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5498048 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 32 Pages |
Abstract
BC risk in female HL survivors increases linearly with radiation dose. HRT does not appear to increase BC risk for HL survivors with therapy-induced early menopause. There are no indications that endogenous and exogenous gonadal hormones affect the radiation dose-response relationship.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Inge M. MSc, Annemieke W.J. PhD, Berthe M.P. MD, PhD, Cécile P.M. MD, PhD, Anna M. MSc, Marie L. PhD, Michael PhD, Augustinus D.G. MD, PhD, Michael PhD, Annegien PhD, Karen R. MSc, Sandra MSc, Marnix L. MD, Josée M. MD, PhD, Richard W.M. MD,